A detailed history of Jnba Financial Advisors transactions in Boston Scientific Corp stock. As of the latest transaction made, Jnba Financial Advisors holds 6,863 shares of BSX stock, worth $620,621. This represents 0.06% of its overall portfolio holdings.

Number of Shares
6,863
Previous 7,298 5.96%
Holding current value
$620,621
Previous $562,000 2.31%
% of portfolio
0.06%
Previous 0.06%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 30, 2024

SELL
$72.96 - $84.0 $31,737 - $36,540
-435 Reduced 5.96%
6,863 $575,000
Q2 2024

Jul 22, 2024

BUY
$67.33 - $77.71 $29,288 - $33,803
435 Added 6.34%
7,298 $562,000
Q1 2024

Apr 26, 2024

SELL
$57.6 - $68.62 $3,571 - $4,254
-62 Reduced 0.9%
6,863 $470,000
Q4 2023

Feb 07, 2024

SELL
$48.64 - $57.81 $3,112 - $3,699
-64 Reduced 0.92%
6,925 $400,000
Q3 2023

Nov 02, 2023

BUY
$50.19 - $54.68 $3,212 - $3,499
64 Added 0.92%
6,989 $369,000
Q1 2023

May 01, 2023

BUY
$45.09 - $50.03 $2,795 - $3,101
62 Added 0.9%
6,925 $346,000
Q4 2022

Feb 06, 2023

SELL
$39.56 - $47.22 $36,434 - $43,489
-921 Reduced 11.83%
6,863 $317,000
Q2 2021

Aug 04, 2021

BUY
$38.58 - $44.24 $25,887 - $29,685
671 Added 9.43%
7,784 $333,000
Q1 2021

May 03, 2021

BUY
$35.27 - $39.67 $8,817 - $9,917
250 Added 3.64%
7,113 $275,000
Q2 2020

Jul 24, 2020

SELL
$30.19 - $39.11 $13,132 - $17,012
-435 Reduced 5.96%
6,863 $241,000
Q3 2019

Nov 01, 2019

SELL
$40.31 - $43.45 $4,031 - $4,345
-100 Reduced 1.35%
7,298 $297,000
Q2 2019

Jul 26, 2019

BUY
$34.91 - $42.98 $3,490 - $4,298
100 Added 1.37%
7,398 $318,000
Q4 2018

Feb 07, 2019

BUY
$31.73 - $39.04 $231,565 - $284,913
7,298 New
7,298 $258,000
Q3 2018

Nov 01, 2018

SELL
$32.83 - $38.63 $239,593 - $281,921
-7,298 Closed
0 $0
Q2 2017

Aug 14, 2017

BUY
N/A
7,298
7,298 $202,000

Others Institutions Holding BSX

About BOSTON SCIENTIFIC CORP


  • Ticker BSX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,431,609,984
  • Market Cap $129B
  • Description
  • Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...
More about BSX
Track This Portfolio

Track Jnba Financial Advisors Portfolio

Follow Jnba Financial Advisors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jnba Financial Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Jnba Financial Advisors with notifications on news.